Find the right department

Behavioral health provider contracting (phone 800-625-2583, fax 216-687-1450 shared with ancillary network).

Behavioral health prior approval requests.

Medical prior approval/care authorizations; select prior approvals can be submitted in ReviewLink.

Care management.

Case management referrals.

Chronic condition management programs.

Clinical drug management (medical drug review).

Clinical quality improvement department.

Coordination of benefits questions/updates.

Payer ID 29076. Email only for EDI setup, trading partner technical support or file issues; not for claim status.

Electronic funds transfer enrollment through One Inc.

Express Scripts prescriber service center.

Express Scripts coverage management for Medical Mutual pharmacy benefits. Prescriber Service Center: 1-800-211-1456.

Ancillary provider contracting (shares fax with behavioral health network).

Southwest Ohio provider contracting.

Provider contracting toll-free line is shared by all regional offices; Northeast Ohio office (see regional office map for your county).

Central Ohio provider contracting.

Northwest Ohio provider contracting.

Use Availity first for eligibility, benefits and claim status; call when unavailable or more information is needed.

Technical problems with the Medical Mutual provider website.

Page shows customer care lines only; no provider services line found. Use number on ID card.

Physician-owned medical practice, not a payer. The insurance page limits acceptance of new patients for several plans; contact the practice about registration. Clinic visit hours are not assumed to be billing-office hours.

Temporary Medicare GLP-1 Bridge demonstration, July 1, 2026–December 31, 2027. Only eligible Part D beneficiaries and the current named formulations qualify: Foundayo tablets, Wegovy injection/HD/tablets and Zepbound KwikPen; single-dose Zepbound pens/vials excluded. Separate from commercial cards, manufacturer PAP and IRA negotiated-price rules. Eligibility and coverage must be confirmed; no price guarantee.

A denied pharmacy claim submitted to the Bridge BIN/PCN is required BEFORE the prescriber submits this request; this is not a requirement for a prior Part D denial. Form submission is restricted to prescribing clinicians. Conditions eligible for regular Part D coverage follow that plan's process. Temporary Medicare GLP-1 Bridge demonstration, July 1, 2026–December 31, 2027. Only eligible Part D beneficiaries and the current named formulations qualify: Foundayo tablets, Wegovy injection/HD/tablets and Zepbound KwikPen; single-dose Zepbound pens/vials excluded. Separate from commercial cards, manufacturer PAP and IRA negotiated-price rules. Eligibility and coverage must be confirmed; no price guarantee.

Temporary Medicare GLP-1 Bridge demonstration, July 1, 2026–December 31, 2027. Only eligible Part D beneficiaries and the current named formulations qualify: Foundayo tablets, Wegovy injection/HD/tablets and Zepbound KwikPen; single-dose Zepbound pens/vials excluded. Separate from commercial cards, manufacturer PAP and IRA negotiated-price rules. Eligibility and coverage must be confirmed; no price guarantee.

Temporary Medicare GLP-1 Bridge demonstration, July 1, 2026–December 31, 2027. Only eligible Part D beneficiaries and the current named formulations qualify: Foundayo tablets, Wegovy injection/HD/tablets and Zepbound KwikPen; single-dose Zepbound pens/vials excluded. Separate from commercial cards, manufacturer PAP and IRA negotiated-price rules. Eligibility and coverage must be confirmed; no price guarantee.

Not a patient case, prescription, PAP or prior-authorization submission inbox. If secure transfer is necessary, follow CMS instructions to arrange it. Temporary Medicare GLP-1 Bridge demonstration, July 1, 2026–December 31, 2027. Only eligible Part D beneficiaries and the current named formulations qualify: Foundayo tablets, Wegovy injection/HD/tablets and Zepbound KwikPen; single-dose Zepbound pens/vials excluded. Separate from commercial cards, manufacturer PAP and IRA negotiated-price rules. Eligibility and coverage must be confirmed; no price guarantee.

CMS ACO ID A5855. Public reporting / administrative contact from the CMS PY2026 dataset, modified April 16, 2026. This is not a claims, eligibility, enrollment, or urgent clinical line. State tags identify states containing counties where more than 1% of assigned beneficiaries reside; they are not a statewide service-coverage or eligibility guarantee. The ACO reporting website was supplied in the dataset and was not individually reviewed in this batch.

Current clean forms page identifies MediCopy as an MRO company and explicitly publishes this email and fax for Disability/FMLA forms. The current FAQ provides the phone extension for form-pricing questions. These channels are not general medical-record release, all-facility submission or payer-claim decision routes. No separate phone hours published. No forms, calls, faxes, emails or payments were submitted.

Current clean contact page directs patients, third-party requesters and potential healthcare partners to the office phone or on-page chat. MediCopy is an MRO company, with separate branded requester workflows still directed to medicopy.net by current MRO guidance. The physical office address does not establish nationwide facility coverage or a universal records-submission destination. Phone hours are not published here.

Current clean ROI page states MediCopy can release records only for healthcare entities that have partnered with it and directs others back to their provider. Patients may complete the linked online authorization, upload the PDF through the linked secure Box route, mail the authorization here, or give it to their doctor’s office. This is authorization-request mail, not proof that all records or third-party submissions use this destination. No fax or public email is published for general patient ROI on this page.

Current clean FAQ directs invoice payment through https://medicopy.invoiced.com/, online chat, mailed checks or a phone payment. The office phone is published in the same FAQ footer. This is a billing route for MediCopy invoices only; a specific check-remittance address is not separately established in this FAQ, so mailingAddress is blank. No invoice, payment transaction, account login or delivery test was performed.

State-specific; no national line confirmed.

MedImpact contact page: appeals submission fax (member and provider appeals form). Not for initial PA requests.

MedImpact contact on the Colorado uniform pharmacy PA request form (effective 1-1-26) and MedImpact contact page (PA submission fax). Check the member ID card: some plans (e.g., Kentucky Medicaid) use dedicated MedImpact lines.

Published in the Ohio Emergency Management Agency local health department dataset, sourced from ODH OneSource and last updated October 5, 2026. The dataset lists this as an active local health department. The update date describes the dataset, not a telephone verification. No county service area is inferred from the office address or location-county field.

For existing customers and their authorized users (account holders) only. This is a software/vendor support line; it cannot answer payer coverage, eligibility or claim-status questions. Page says customers can log in to the Customer Service area and enter a task, or call this number anytime. Also the Canton, MA headquarters number.

Employment assistance only; not customer or order support.

General Medline orders, products or account opening; not a pharmacy benefit manager.

Official contact page confirms home-care orders/products. Direct download returned 403; the official-page web-read snapshot is preserved.

Medline customer category; not patient diagnostic-result support.

Public business email for news/media/speaker requests only.

Public business email for news/media/speaker requests only.

Separate OEM/animal-health customer channel.

The same number is also published for Education questions.

Surgery-center customer channel.